FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Chinese Drug Firm Terminates FDA Inspection

[ Price : $8.95]

FDA says it found significant CGMP violations at Chinas Fercy Personal Care Products during an inspection cut short by the company...

FDA OKs First Breast Ultrasound for Dense Breast Tissue

[ Price : $8.95]

FDA approves U-Systems some-v Automated Breast Ultrasound System, the first ultrasound device for use in combination with a standa...

FDA Pitches QbD to Small Business to Improve Quality

[ Price : $8.95]

A new FDA publication makes a pitch to small businesses for improved drug quality through a quality-by-design approach.

FDA 'Fast Track for Marburg, Ebola Virus Therapeutics

[ Price : $8.95]

FDA grants Sarepta Therapeutics fast track status for developing AVI-7288 and AVI-7537, indicated for treating Marburg virus and E...

FDA Designates Delafloxacin as a GAIN Program Candidate

[ Price : $8.95]

FDA designates Rib-X Pharmaceuticals' delafloxacin as a Qualified Infectious Disease Product, indicated for treating acute bacteri...

Targacept Scraps ADHD Drug Development

[ Price : $8.95]

Targacept stops development of its inattentive-predominant attention deficit/hyperactivity disorder drug TC-5619 after disappointi...

Pfizer Presenting Data on Tofacitinib for Rheumatoid Arthritis

[ Price : $8.95]

Pfizer says it will present 14 abstracts next month at the American College of Rheumatology for tofacitinib, an investigational dr...

FDA OKs Wockhardt Generic Prevacid

[ Price : $8.95]

FDA approves a Wockhardt ANDA for lansoprazole 15mg and 30 mg delayed-release capsules, a generic copy of Takedas ulcer-treating P...

FDA Corrects Notice on Generic Drug Facilities Self-Identification

[ Price : $8.95]

Federal Register Notice: FDA corrects a docket number in an 8/27 Federal Register notice on a draft guidance on self-identificatio...

Trial System Not Ready for Personalized Medicine: Woodcock

[ Price : $8.95]

CDER director Janet Woodcock tells a Friends of Cancer Research conference she doesnt think the U.S. clinical trial system is up t...